Skip to content
Contact Us
About
Our Company
Executive Team
Board of Directors
Scientific Founders
Technology
Bacteriophage background
Phage therapy
Biomarker discovery
Pipeline
Investors
Newsroom
Publications
Careers
+972-72-3942377
info@biomx.com
Connect with us on LinkedIn
Newsroom
News
Press Releases
Events
Year, latest to oldest
Year, oldest to latest
May 3, 2023
The Economist - Western firms are becoming interested in a Soviet medicine
Apr 17, 2023
Nature Biotechnology - Microbiome-friendly phages join the campaign for better antimicrobials
Feb 23, 2023
CF news today - Phage cocktail BX004 safe, seen to reduce P. aeruginosa in small trial
Jun 28, 2022
BioSpace - Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn's Trial
Jan 11, 2022
Independent - Viruses that help: Is bacteriophage therapy the future of medicine?
Jan 5, 2022
Cystic Fibrosis News Today - CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
Apr 9, 2021
Phase 2 Trial of BX004, Phage Therapy for Bacterial Infections, Advancing
Apr 7, 2021
Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit
Oct 18, 2020
BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates
Nov 20, 2019
BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Dec 12, 2020
Jefferies 2020 Virtual London Healthcare Conference
Sorry, there are no items that match your search.
Please refine your search and try again.
Sign up for the latest updates
Join our mailing list to receive company updates
delivered to your inbox
Join the list
Reach Us
22 Einstein St., Floor 4
Ness Ziona 7414003
Israel
+972-72-3942377
info@biomx.com
Connect with us on LinkedIn